FOXO3 and cancer: Forkhead box M1 (FOXM1) and FOXO3a have been observed to compete in binding to similar DNA sequences, which often results in antagonized transcriptional output that has recently been related to genotoxic drug resistance and the response of various cancers to chemotherapy [17, 18].